相关实验视频
Updated: Jun 27, 2026

07:09
Isolation of Adipose Tissue Immune Cells
Published on: May 22, 2013
36.2K
在COVID-19患者中循环阿迪波金水平的变化
Tomasz Wikar1,2, Mateusz Rubinkiewicz1, Dominika Stygar3
12nd Department of General Surgery, Jagiellonian University Medical College, 31-066 Kraków, Poland.
Journal of clinical medicine
|August 29, 2024
概括
COVID-19 感染显著降低了视沙丁水平,在住院期间正常化. 莱普水平在COVID-19患者中没有显著差异,但与BMI相关. 需要进一步的研究.
科学领域:
- 生物化学 生物化学
- 免疫学 免疫学 免疫学
- 传染性疾病 传染性疾病
背景情况:
- 由SARS-CoV-2引起的COVID-19大流行给全球健康带来了重大挑战.
- 了解COVID-19患者的炎症反应对于有效管理至关重要.
- 阿迪波基因,如维斯法丁和丁,在炎症和代谢过程中起作用.
研究的目的:
- 为了研究与健康对照组相比,COVID-19患者血清维斯法廷和丁度的变化.
- 探索这些阿迪波金与疾病进展或严重程度之间的相关性.
- 评估维斯法丁和瘦素作为COVID-19生物标志物的潜力.
主要方法:
- 血清样本从40名COVID-19患者和24名健康对照患者在入院时和第7天收集.
- 使用酶免疫检测或ELISA套件测量了维斯法丁和瘦素度.
- 统计分析包括沙皮罗-威尔克测试,曼-惠特尼U测试,克鲁斯卡尔-瓦利斯ANOVA和斯皮尔曼等级相关性.
主要成果:
- 与对照组相比,COVID-19患者在入院时的血清维斯法廷水平显著降低 (p < 0.001).
- 在COVID-19患者中的Visfatin水平在住院7天后正常化至控制水平.
- 在COVID-19患者和对照人群之间没有观察到瘦素水平的显著差异 (p = 0.270,p = 0.129);然而,瘦素与BMI正相关 (r = 0.66,p = 0.00).
结论:
- COVID-19 感染的发作与视法丁水平显著降低有关.
- 莱普在COVID-19病变发生中的作用需要进一步调查,其水平受到BMI的影响.
- 需要进行额外的研究,以澄清维斯法丁和丁在SARS-CoV-2感染中的作用及其预后价值.
相关概念视频
Measurement of Blood Pressure
Assessing blood pressure is a standard procedure executed in virtually all medical environments. The method utilized today was established over a hundred years ago by an innovative Russian doctor, Dr. Nikolai Korotkoff. The soft ticking noise, known as Korotkoff sounds, heard while taking blood pressure readings results from turbulent blood flow within the vessels. The apparatus required for this procedure includes a sphygmomanometer, a blood pressure cuff attached to a gauge, and a stethoscope.
Interpreting Run Charts
Run charts, essentially line graphs plotted over time, serve as fundamental yet effective tools for process analysis. They chronicle data sequentially, facilitating the identification of trends, shifts, or cyclical movements. This graphical representation is instrumental in determining whether a process is stable or exhibits signs of potential instability indicative of special cause variation. In the healthcare domain, run charts depict infection rates over time, enabling hospitals to monitor...
Heart Failure VI: Adjunct Therapies
Additional therapies for treating patients with heart failure (HF) may include procedural interventions, supplemental oxygen, the management of sleep disorders, and nutritional therapy.Procedural InterventionsImplantable Cardioverter-Defibrillator: For patients at risk of life-threatening arrhythmias due to severe left ventricular dysfunction, an Implantable Cardioverter-Defibrillator (ICD) can detect and terminate these arrhythmias, preventing sudden cardiac death and improving survival rates.

